Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches

Table 4 Antioxidant potentials of isolated compounds from N. thomsonianum

Compound	Mol wt	Conc (μg/mL)	Percent Inhibition (mean ± SEM)	IC₅₀ (μg/mL)	IC₅₀ (μM)
Nt01	216	500 250 125 62.50 31.25	88.35 ± 0.89^* 84.36 ± 1.15^* 79.62 ± 0.03^ 76.16 ± 0.12^* 73.67 ± 0.35^***	2.02	4.70
Nt02	112	500 250 125 62.50 31.25	86.60 ± 0.00^*** 79.32 ± 0.40^* 74.78 ± 0.44^* 69.08 ± 0.66^* 64.40 ± 0.40^***	8.97	41.53
Nt03	430	500 250 125 62.50 31.25	90.69 ± 0.14^ns 87.14 ± 0.49^ns 84.44 ± 0.15^ns 82.72 ± 0.11^ns 79.85 ± 0.17^*	0.421	2.75
Ascorbic acid	176	500 250 125 62.50 31.25	91.75 ± 0.42 88.47 ± 0.71 85.20 ± 0.49 83.42 ± 1.55 81.62 ± 0.58	0.314	1.78

ISSN: 2662-7671